Income Statement
Balance Sheet
Cash Flow
| Line Item | Q4 2025Oct 31, 2025 | Q4 2024Oct 31, 2024 |
|---|---|---|
| Total Revenue | 0.00 | 0.00 |
| Operating Revenue | 0.00 | 0.00 |
| Selling General And Administration | 1.9M | 439,363 |
| General And Administrative Expense | 1.7M | 435,863 |
| Depreciation And Amortization In Income Statement | 9,205 | 2,983 |
| Operating Expense | 1.9M | 442,346 |
| Operating Income | -1.9M | -442,346 |
| EBIT | -1.9M | -442,910 |
| Interest Expense | 1,439 | 852.00 |
| Interest Expense Non Operating | 1,439 | 852.00 |
| Interest Income | 27,063 | 0.00 |
| Interest Income Non Operating | 27,063 | 0.00 |
| Net Interest Income | 25,624 | -852.00 |
| Other Income Expense | -37,385 | -564.00 |
| Gain On Sale Of Security | -37,385 | -564.00 |
| Pretax Income | -1.9M | -443,762 |
| Tax Effect Of Unusual Items | 0.00 | 0.00 |
| Net Income From Continuing And Discontinued Operation | -1.9M | -443,762 |
| Net Income From Continuing Operation Net Minority Interest | -1.9M | -443,762 |
| Net Income Including Noncontrolling Interests | -1.9M | -443,762 |
| Net Income Common Stockholders | -1.9M | -443,762 |
| Net Income | -1.9M | -443,762 |
| EBITDA | -1.9M | -439,927 |
| Normalized EBITDA | -1.8M | -439,363 |
| Reconciled Depreciation | 9,205 | 2,983 |
| Basic EPS | -0.02 | -0.00 |
| Diluted EPS | -0.02 | -0.00 |
| Basic Average Shares | 103.8M | 103.8M |
| Diluted Average Shares | 103.8M | 103.8M |
| Total Unusual Items | -37,385 | -564.00 |
| Total Unusual Items Excluding Goodwill | -37,385 | -564.00 |
| Tax Rate For Calcs | 0.00 | 0.00 |
| Normalized Income | -1.9M | -443,198 |
| Amortization | 9,205 | 2,983 |
| Amortization Of Intangibles Income Statement | 9,205 | 2,983 |
| Depreciation Amortization Depletion Income Statement | 9,205 | 2,983 |
| Diluted NI Availto Com Stockholders | -1.9M | -443,762 |
| Net Income Continuous Operations | -1.9M | -443,762 |
| Net Non Operating Interest Income Expense | 25,624 | -852.00 |
| Other Gand A | 1.4M | 435,863 |
| Salaries And Wages | 392,687 | 0.00 |
| Selling And Marketing Expense | 121,964 | 3,500 |
| Total Expenses | 1.9M | 442,346 |
| Line Item | Q4 2025Oct 31, 2025 | Q4 2024Oct 31, 2024 |
|---|---|---|
| Cash And Cash Equivalents | 2.3M | -- |
| Cash Cash Equivalents And Short Term Investments | 2.3M | -- |
| Cash Financial | 2.3M | -- |
| Receivables | 142,721 | -- |
| Prepaid Assets | 70,248 | -- |
| Current Assets | 4.1M | -- |
| Gross PPE | 2.5M | -- |
| Net PPE | 2.5M | -- |
| Total Non Current Assets | 2.5M | -- |
| Total Assets | 6.5M | -- |
| Current Debt And Capital Lease Obligation | 35,839 | -- |
| Payables And Accrued Expenses | 538,234 | -- |
| Other Current Liabilities | 2.2M | -- |
| Current Liabilities | 2.8M | -- |
| Long Term Capital Lease Obligation | 0.00 | -- |
| Total Non Current Liabilities Net Minority Interest | 0.00 | -- |
| Total Liabilities Net Minority Interest | 2.8M | -- |
| Common Stock | 5.3M | -- |
| Capital Stock | 5.3M | -- |
| Retained Earnings | -4.1M | -- |
| Gains Losses Not Affecting Retained Earnings | 2.6M | -- |
| Other Equity Adjustments | 2.6M | -- |
| Common Stock Equity | 3.8M | -- |
| Stockholders Equity | 3.8M | -- |
| Total Equity Gross Minority Interest | 3.8M | -- |
| Total Capitalization | 3.8M | -- |
| Net Tangible Assets | 3.8M | -- |
| Tangible Book Value | 3.8M | -- |
| Working Capital | 1.3M | -- |
| Invested Capital | 3.8M | -- |
| Total Debt | 35,839 | -- |
| Share Issued | 103.8M | -- |
| Ordinary Shares Number | 103.8M | -- |
| Buildings And Improvements | 33,750 | -- |
| Capital Lease Obligations | 35,839 | -- |
| Current Capital Lease Obligation | 35,839 | -- |
| Derivative Product Liabilities | 0.00 | -- |
| Non Current Deferred Liabilities | 0.00 | -- |
| Other Properties | 2.4M | -- |
| Restricted Cash | 1.5M | -- |
| Taxes Receivable | 142,721 | -- |
| Line Item | Q4 2025Oct 31, 2025 | Q4 2024Oct 31, 2024 |
|---|---|---|
| Operating Cash Flow | -1.2M | -122,936 |
| Cash Flow From Continuing Operating Activities | -1.2M | -122,936 |
| Depreciation And Amortization | 9,205 | 2,983 |
| Depreciation Amortization Depletion | 9,205 | 2,983 |
| Stock Based Compensation | 455,187 | 0.00 |
| Change In Working Capital | 138,838 | 76,991 |
| Change In Receivables | -91,508 | -5,734 |
| Change In Payables And Accrued Expense | 214,142 | 86,325 |
| Other Non Cash Items | 37,689 | 240,852 |
| Capital Expenditure | -1.1M | -- |
| Purchase Of PPE | -1.1M | 0.00 |
| Net PPE Purchase And Sale | -1.1M | 0.00 |
| Investing Cash Flow | -1.1M | 0.00 |
| Cash Flow From Continuing Investing Activities | -1.1M | 0.00 |
| Repayment Of Debt | -10,393 | -3,428 |
| Net Issuance Payments Of Debt | -10,393 | -3,428 |
| Issuance Of Capital Stock | 74,960 | 10,000 |
| Net Common Stock Issuance | 74,960 | 10,000 |
| Financing Cash Flow | 1.7M | 6,572 |
| Cash Flow From Continuing Financing Activities | 1.7M | 6,572 |
| Changes In Cash | -612,428 | -116,364 |
| Beginning Cash Position | 4.5M | 140,644 |
| End Cash Position | 3.8M | 24,280 |
| Free Cash Flow | -2.3M | -122,936 |
| Change In Prepaid Assets | 16,204 | -3,600 |
| Common Stock Issuance | 74,960 | 10,000 |
| Depreciation | 9,205 | 2,983 |
| Gain Loss On Investment Securities | 34,905 | -- |
| Long Term Debt Payments | -10,393 | -3,428 |
| Net Income From Continuing Operations | -1.9M | -443,762 |
| Net Long Term Debt Issuance | -10,393 | -3,428 |
| Net Other Financing Charges | 1.5M | -- |
| Operating Gains Losses | 34,905 | -- |
| Proceeds From Stock Option Exercised | 150,000 | 0.00 |